KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

NovoCure (NVCR) Times Interest Earned (2016 - 2022)

Historic Times Interest Earned for NovoCure (NVCR) over the last 9 years, with Q2 2022 value amounting to -$9.48.

  • NovoCure's Times Interest Earned rose 2749.92% to -$9.48 in Q2 2022 from the same period last year, while for Mar 2023 it was -$66.86, marking a year-over-year decrease of 90994.02%. This contributed to the annual value of -$5.73 for FY2021, which is 33166.26% down from last year.
  • According to the latest figures from Q2 2022, NovoCure's Times Interest Earned is -$9.48, which was up 2749.92% from -$0.47 recorded in Q1 2022.
  • NovoCure's Times Interest Earned's 5-year high stood at $3.77 during Q3 2020, with a 5-year trough of -$13.08 in Q2 2021.
  • Its 5-year average for Times Interest Earned is -$2.27, with a median of -$1.79 in 2018.
  • As far as peak fluctuations go, NovoCure's Times Interest Earned skyrocketed by 412136.6% in 2020, and later tumbled by 131807.81% in 2022.
  • Quarter analysis of 5 years shows NovoCure's Times Interest Earned stood at -$4.01 in 2018, then soared by 102.19% to $0.09 in 2019, then skyrocketed by 4121.37% to $3.7 in 2020, then plummeted by 390.65% to -$10.76 in 2021, then grew by 11.85% to -$9.48 in 2022.
  • Its Times Interest Earned stands at -$9.48 for Q2 2022, versus -$0.47 for Q1 2022 and -$10.76 for Q4 2021.